Carroll Jill — SEC Form 4 filings
SEC reporting owner CIK 1598542. 5 Form 4 filings on record with FilingPulse; latest filed 2026-05-01.
Transaction summary — filings shown
Covers all 5 filings on record, filed 2024-03-25 to 2026-05-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 277,778 shares, $5,000,004 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 504,263 shares, $35,575,755 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 504,263 shares @ $70.55 ($35,575,755) in Arcellx, Inc., filed 2024-03-25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Arcellx, Inc. (ACLX) | Director | 4 | — | 1 leg · 504,263 sh · $35,575,755 | 6 |
| Avalyn Pharma Inc. (AVLN) | Director | 1 | 1 leg · 277,778 sh · $5,000,004 | — | 4 |
Form 4 filings — Carroll Jill
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-01 | 4 | Avalyn Pharma Inc. (AVLN) | Conversion (C): 1,419,298 · Conversion (C): 489,486 · Purchase (P): 277,778 @ $18 · Conversion (C): 27,309,719 (derivative) · Conversion (C): 9,418,561 (derivative) | EDGAR |
| 2026-04-28 | 4 | Arcellx, Inc. (ACLX) | Code (U): 1,479,148 · Disposition to issuer (D): 11,459 (derivative) · Disposition to issuer (D): 8,011 (derivative) · Disposition to issuer (D): 9,174 (derivative) | EDGAR |
| 2025-05-30 | 4 | Arcellx, Inc. (ACLX) | Grant/award (A): 9,174 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Arcellx, Inc. (ACLX) | Grant/award (A): 8,011 (derivative) @ $0 | EDGAR |
| 2024-03-25 | 4 | Arcellx, Inc. (ACLX) | Sale (S): 504,263 @ $70.55 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1598542 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →